双室变异型致心律失常性右室心肌病1例

肖栋; 叶良海; 陈若诗; 李穗吉

doi:10.13201/j.issn.1001-1439.2022.03.018

双室变异型致心律失常性右室心肌病1例

- 1.
  厦门大学附属心血管病医院心内科(福建厦门，361006)
- 2.
  厦门大学附属心血管病医院影像科
- 3.
  厦门长庚医院内科

详细信息

通讯作者: 李穗吉，E-mail：244129234@qq.com

中图分类号: R541.7

收稿日期: 2021-08-19

刊出日期: 2022-03-13

Biventricular variant arrhythmogenic right ventricular cardiomyopathy—one case report

- 1.
  Department of Cardiology, Cardiovascular Hospital Affiliated to Xiamen University, Xiamen, Fujian, 361006, China
- 2.
  Department of Imaging, Cardiovascular Hospital Affiliated to Xiamen University
- 3.
  Department of Internal Medicine, Xiamen Chang Gung Hospital

More Information

Corresponding author: LI Suiji, E-mail: 244129234@qq.com

Received Date: 19 August 2021

Publish Date: 13 March 2022

摘要

- 致心律失常性右室心肌病 /
- 双室变异
Abstract: A 38-year-old male patient was admitted to hospital with shortness of breath 1 month after exercise. Holter electrocardiogram showed sinus tachycardia, frequent premature ventricular tachycardia, and paroxysmal ventricular tachycardia. Echocardiography showed whole-heart enlargement, mainly in the right ventricle. We considered that the patient had arrhythmogenic right ventricular cardiomyopathy. He was discharged from the hospital after drug treatment. No adverse cardiovascular events occurred during the 8-month follow-up.
- arrhythmogenic right ventricular cardiomyopathy /
- biventricular variant

HTML全文

图 1 心电图

Figure 1. EKG

下载: 全尺寸图片幻灯片

图 2 心脏磁共振

Figure 2. CMI

下载: 全尺寸图片幻灯片

图 3 心脏磁共振

Figure 3. CMI

下载: 全尺寸图片幻灯片

参考文献(16)

[1]	梁士楚, 王翠, 常龄予, 等. 基于GEO数据库芯片的致心律失常性右室心肌病关键基因筛选与生物信息学分析[J]. 临床心血管病杂志, 2020, 36(6): 516-522. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB202006006.htm
[2]	Romero J, Mejia-Lopez E, Manrique C, et al. Arrhythmogenic Right Ventricular Cardiomyopathy(ARVC/D): a systematic literature review[J]. Clin Med Insights Cardiol, 2013, 7: 97-114. doi: 10.4137/CMC.S10940
[3]	马延仃, 弓向荣. 累及左心室的致心律失常性右室心肌病临床表型分析[J]. 临床心血管病杂志, 2019, 35(11): 1041-1046. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201911015.htm
[4]	Sinagra G, Cappelletto C, DE Luca A, et al. Focus on arrhythmogenic right ventricular cardiomyopathy[J]. Eur Heart J Suppl, 2020, 22(Suppl L): L129-L135. doi: 10.1093/eurheartj/suaa152
[5]	Bosman LP, Te Riele A. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification[J]. Heart, 2022, 108(2): 90-97. doi: 10.1136/heartjnl-2021-319113
[6]	Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society(HRS)and the European Heart Rhythm Association(EHRA)[J]. Europace, 2011, 13(8): 1077-1109. doi: 10.1093/europace/eur245
[7]	Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria[J]. Circulation, 2010, 121(13): 1533-1541. doi: 10.1161/CIRCULATIONAHA.108.840827
[8]	Corrado D, van Tintelen PJ, McKenna WJ, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis[J]. Eur Heart J, 2020, 41(14): 1414-1429.
[9]	Zimmerman SL. Arrhythmogenic right ventricular cardiomyopathy/dysplasia: an updated imaging approach[J]. Magn Reson Imaging Clin N Am, 2015, 23(1): 69-79. doi: 10.1016/j.mric.2014.09.001
[10]	Corrado D, Basso C, Nava A, et al. Sudden death in young people with apparently isolated mitral valve prolapse[J]. G Ital Cardiol, 1997, 27(11): 1097-1105.
[11]	Sen-Chowdhry S, Morgan RD, Chambers JC, et al. Arrhythmogenic cardiomyopathy: etiology, diagnosis, and treatment[J]. Annu Rev Med, 2010, 61: 233-253. doi: 10.1146/annurev.med.052208.130419
[12]	Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity[J]. J Am Coll Cardiol, 2008, 52(25): 2175-2187. doi: 10.1016/j.jacc.2008.09.019
[13]	Aquaro GD, Barison A, Todiere G, et al. Usefulness of Combined Functional Assessment by Cardiac Magnetic Resonance and Tissue Characterization Versus Task Force Criteria for Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy[J]. Am J Cardiol, 2016, 118(11): 1730-1736. doi: 10.1016/j.amjcard.2016.08.056
[14]	Saguner AM, Brunckhorst C, Duru F. Arrhythmogenic ventricular cardiomyopathy: A paradigm shift from right to biventricular disease[J]. World J Cardiol, 2014, 6(4): 154-174. doi: 10.4330/wjc.v6.i4.154
[15]	Link MS, Laidlaw D, Polonsky B, et al. Ventricular arrhythmias in the North American multidisciplinary study of ARVC: predictors, characteristics, and treatment[J]. J Am Coll Cardiol, 2014, 64(2): 119-125. doi: 10.1016/j.jacc.2014.04.035
[16]	Gasperetti A, Targetti M, Olivotto I. Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: The importance of optimal beta-blocker dose titration[J]. Int J Cardiol, 2021, 338: 150-151. doi: 10.1016/j.ijcard.2021.06.009